ENDOMETRIAL STROMAL SARCOMA

This adverse event was reported 50 times

These drugs are most commonly taken by patients reporting ENDOMETRIAL STROMAL SARCOMA:

# Drug Count
0 PAZOPANIB HYDROCHLORIDE 7
1 ESTRADIOL 6
2 ESTRADIOL GEL 0.1% 6
3 ESTRADIOL TRANSDERMAL 6
4 ESTRADIOL, 6
5 PROGESTERONE 6
6 LETROZOLE 4
7 LETROZOLE TABLETS 4
8 LEUPROLIDE ACETATE 4
9 PACLITAXEL 4
See all common drugs associated with ENDOMETRIAL STROMAL SARCOMA

ENDOMETRIAL STROMAL SARCOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TOREMIFENE CITRATE 2 0.0046
1 DEXRAZOXANE FOR INJECTION 2 0.0021
2 TRABECTEDIN 2 0.0009
3 ERDAFITINIB 1 0.0008
4 MEGESTROL ACETATE 2 0.0005
5 DACARBAZINE 2 0.0003
6 PAZOPANIB HYDROCHLORIDE 7 0.0003
7 PROGESTERONE 6 0.0003
8 IFOSFAMIDE FOR INJECTION 3 0.0001
9 ANASTROZOLE TABLETS 3 0.0001
See all drugs enriched for association with ENDOMETRIAL STROMAL SARCOMA

ENDOMETRIAL STROMAL SARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Progesterone [EPC] 6 0.0003
2 Aromatase Inhibitor [EPC] 7 0.0001
3 Microtubule Inhibitor [EPC] 6 0.0000
4 Estrogen [EPC] 6 0.0000
5 Estrogen Receptor Antagonist [EPC] 1 0.0000
6 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
7 Alkylating Drug [EPC] 3 0.0000
8 Progestin [EPC] 3 0.0000
9 Purine Antimetabolite [EPC] 1 0.0000
See all drug classes enriched for association with ENDOMETRIAL STROMAL SARCOMA